NYSEAMERICAN : PTHS
Pelthos Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 9.4 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 35.99M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Pelthos Therapeutics Inc. (PTHS) reported revenue of 43.30M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 43.30M | 16.80M | ||||
| Cost of Revenue | 10.58M | 5.22M | 1.18M | 391.73K | 209.05K | |
| Gross Profit | 32.73M | 11.58M | -1.18M | -391.73K | -209.05K | |
| Selling, General & Admin | 84.35M | 41.43M | 6.39M | 4.28M | 1.93M | 629.95K |
| Research & Development | 2.58M | |||||
| Amortization of Goodwill & Intangibles | 3.63M | 1.56M | ||||
| Operating Expenses | 87.98M | 42.99M | 6.39M | 6.86M | 1.93M | 629.95K |
| Operating Income | -55.25M | -31.41M | -7.57M | -6.86M | -2.32M | -839.00K |
| Interest Expense | -7.40M | -3.01M | -786.00K | -518.51K | -140.43K | -253.00 |
| Interest & Investment Income | 5.00K | 5.00K | 402.00K | |||
| Other Non Operating Income (Expenses) | -28.32M | -14.98M | ||||
| EBT Excluding Unusual Items | -90.97M | -49.40M | -7.96M | -7.38M | -2.46M | -839.25K |
| Merger & Restructuring Charges | -1.02M | -1.02M | ||||
| Asset Writedown | -285.00K | -285.00K | ||||
| Other Unusual Items | -1.50M | 243.86K | ||||
| Pretax Income | -93.78M | -50.71M | -7.96M | -7.38M | -2.46M | -595.39K |
| Income Tax Expense | -7.39M | -7.39M | ||||
| Net Income | -86.39M | -43.32M | -7.96M | -7.38M | -2.46M | -595.39K |
| Net Income to Common | -86.39M | -43.32M | -7.96M | -7.38M | -2.46M | -595.39K |
| Shares Outstanding (Basic) | 3.28M | 1.88M | 557.45K | 127.65K | 43.53K | |
| Shares Outstanding (Diluted) | 3.28M | 1.88M | 557.45K | 127.65K | 43.53K | |
| EPS (Basic) | -26.36 | -23.04 | -14.27 | -57.82 | -56.48 | |
| EPS (Diluted) | -26.36 | -23.04 | -14.27 | -57.82 | -56.48 | |
| Free Cash Flow | -42.60M | -22.69M | -5.79M | -981.03K | -1.57M | -1.59M |
| Free Cash Flow Per Share | -13.00 | -12.06 | -10.39 | -7.68 | -36.00 | |
| Gross Margin | 75.58% | 68.94% | ||||
| Operating Margin | -127.60% | -187.01% | ||||
| Profit Margin | -199.50% | -257.93% | ||||
| Free Cash Flow Margin | -98.37% | -135.09% | ||||
| EBITDA | -29.12M | -1.63M | ||||
| EBITDA Margin | -173.40% | |||||
| D&A For EBITDA | 2.29M | 690.45K | ||||
| EBIT | -55.25M | -31.41M | -7.57M | -6.86M | -2.32M | -839.00K |
| EBIT Margin | -127.60% | -187.01% | ||||
| Revenue as Reported | 43.30M | 16.80M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 24.19M | 17.97M | 513.00K | 96.39K | 55.07K | |
| Cash & Short-Term Investments | 24.19M | 17.97M | 513.00K | 96.39K | 55.07K | |
| Receivables | 14.48M | 8.86M | ||||
| Inventory | 21.47M | 23.57M | ||||
| Prepaid Expenses | 496.00K | 1.21M | ||||
| Restricted Cash | 368.00K | 50.00K | ||||
| Other Current Assets | 2.35M | 1.75M | 856.00K | |||
| Total Current Assets | 63.36M | 53.41M | 1.37M | 96.39K | 55.07K | |
| Property, Plant & Equipment | 11.92M | 12.84M | ||||
| Goodwill | 24.68M | 24.68M | ||||
| Other Intangible Assets | 37.40M | 39.47M | ||||
| Total Assets | 137.36M | 130.40M | 1.37M | 96.39K | 55.07K | |
| Accounts Payable | 5.85M | 2.99M | 1.90M | 4.62M | 2.99M | 2.58M |
| Accrued Expenses | 20.75M | 15.36M | 645.95K | 221.88K | ||
| Short-Term Debt | 2.19M | 1.27M | 540.43K | |||
| Current Portion of Leases | 645.00K | 635.00K | ||||
| Current Unearned Revenue | 729.00K | 966.00K | ||||
| Other Current Liabilities | 3.99M | 6.04M | 5.39K | 5.39K | ||
| Total Current Liabilities | 31.96M | 25.99M | 4.08M | 6.54M | 3.76M | 2.58M |
| Long-Term Debt | 69.91M | 31.44M | 1.10M | |||
| Long-Term Leases | 2.55M | 2.75M | ||||
| Long-Term Unearned Revenue | 1.09M | 1.28M | ||||
| Other Long-Term Liabilities | 33.34M | 30.05M | ||||
| Total Liabilities | 138.86M | 91.52M | 4.08M | 6.54M | 3.76M | 3.68M |
| Common Stock | 391.00 | 111.00 | ||||
| Additional Paid-In Capital | 109.70M | 103.67M | 18.76M | 7.07M | 2.43M | |
| Retained Earnings | -113.28M | -64.79M | -21.48M | -13.52M | -6.14M | -3.68M |
| Total Common Equity | -1.50M | 38.88M | -2.71M | -6.44M | -3.71M | -3.68M |
| Shareholders' Equity | -1.50M | 38.88M | -2.71M | -6.44M | -3.71M | -3.68M |
| Total Liabilities & Equity | 137.36M | 130.40M | 1.37M | 96.39K | 55.07K | |
| Total Debt | 73.11M | 34.83M | 2.19M | 1.27M | 540.43K | 1.10M |
| Net Cash (Debt) | -48.92M | -16.86M | -1.67M | -1.17M | -485.36K | -1.10M |
| Net Cash Per Share | -14.93 | -8.96 | -3.00 | -9.18 | -11.15 | |
| Filing Date Shares Outstanding | 3.83M | 3.36M | 610.38K | 587.78K | 111.11K | |
| Total Common Shares Outstanding | 3.72M | 3.23M | 610.38K | 391.43K | 111.11K | |
| Working Capital | 31.40M | 27.42M | -2.71M | -6.44M | -3.71M | -2.58M |
| Book Value Per Share | -0.40 | 12.02 | -4.45 | -16.46 | -33.36 | |
| Tangible Book Value | -63.58M | -25.27M | -2.71M | -6.44M | -3.71M | -3.68M |
| Tangible Book Value Per Share | -17.10 | -7.81 | -4.45 | -16.46 | -33.36 | |
| Machinery | 2.16M | 1.96M | ||||
| Construction In Progress | 1.52M | 1.51M | ||||
| Leasehold Improvements | 5.99M | 5.97M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -86.39M | -43.32M | -7.96M | -7.38M | -2.46M | -595.39K |
| Depreciation & Amortization | 5.32M | 2.36M | ||||
| Other Amortization | 432.00K | 259.00K | 692.00K | 188.12K | 140.43K | |
| Asset Writedown & Restructuring Costs | 285.00K | 285.00K | ||||
| Stock-Based Compensation | 9.23M | 5.46M | 1.80M | 1.73M | 110.15K | |
| Other Operating Activities | 34.74M | 18.44M | -363.00K | 2.43M | -241.79K | |
| Change in Accounts Receivable | -14.43M | -8.81M | ||||
| Change in Inventory | 3.15M | 1.78M | ||||
| Change in Accounts Payable | 1.08M | 1.36M | 1.18M | 1.63M | 413.60K | -827.70K |
| Change in Unearned Revenue | -1.01M | -589.00K | ||||
| Change in Other Net Operating Assets | 12.69M | 7.58M | -1.14M | 424.07K | 227.26K | 71.87K |
| Operating Cash Flow | -42.30M | -22.59M | -5.79M | -981.03K | -1.57M | -1.59M |
| Capital Expenditures | -295.00K | -99.00K | ||||
| Cash Acquisitions | -5.14M | -5.14M | ||||
| Investing Cash Flow | -5.43M | -5.24M | ||||
| Short-Term Debt Issued | 693.00K | 536.00K | 766.94K | 400.00K | ||
| Long-Term Debt Issued | 17.90M | 800.05K | 1.10M | |||
| Total Debt Issued | 47.30M | 18.59M | 536.00K | 766.94K | 1.20M | 1.10M |
| Short-Term Debt Repaid | -845.00K | -215.00K | ||||
| Total Debt Repaid | -2.66M | -845.00K | -215.00K | |||
| Net Debt Issued (Repaid) | 44.64M | 17.75M | 321.00K | 766.94K | 1.20M | 1.10M |
| Issuance of Common Stock | 206.00K | 206.00K | 6.05M | 255.41K | 422.17K | 493.06K |
| Repurchase of Common Stock | -75.00K | |||||
| Other Financing Activities | -92.00K | |||||
| Financing Cash Flow | 72.23M | 45.34M | 6.21M | 1.02M | 1.62M | 1.59M |
| Net Cash Flow | 24.50M | 17.51M | 417.00K | 41.32K | 55.07K | |
| Free Cash Flow | -42.60M | -22.69M | -5.79M | -981.03K | -1.57M | -1.59M |
| Free Cash Flow Margin | -98.37% | -135.09% | ||||
| Free Cash Flow Per Share | -13.00 | -12.06 | -10.39 | -7.68 | -36.00 | |
| Levered Free Cash Flow | -36.57M | -24.65M | -6.96M | -640.57K | ||
| Unlevered Free Cash Flow | -32.38M | -23.03M | -7.16M | -504.62K | ||
| Cash Interest Paid | 1.49M | 19.00K | ||||
| Change in Working Capital | -5.91M | -6.07M | 35.00K | 2.05M | 640.86K | -755.83K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 42.79M | 95.69M | 3.86M | |||
| Enterprise Value | 91.71M | 84.96M | 4.90M | |||
| Last Close Price | 9.40 | 31.00 | 6.41 | |||
| PS Ratio | 0.83 | 5.70 | ||||
| PB Ratio | 2.46 | -1.42 | ||||
| EV/Sales Ratio | 1.96 | 5.06 | ||||
| Debt / Equity Ratio | -48.71 | 0.90 | -0.81 | -0.20 | -0.15 | -0.30 |
| Net Debt / Equity Ratio | -32.59 | 0.43 | -0.62 | -0.18 | -0.13 | -0.30 |
| Net Debt / EBITDA Ratio | -0.58 | -0.30 | ||||
| Net Debt / FCF Ratio | -1.15 | -0.74 | -0.29 | -1.20 | -0.31 | -0.69 |
| Asset Turnover | 0.63 | 0.26 | ||||
| Quick Ratio | 1.21 | 1.03 | 0.13 | 0.01 | 0.01 | |
| Current Ratio | 1.98 | 2.06 | 0.34 | 0.01 | 0.01 | |
| Return on Equity (ROE) | -239.55% | |||||
| Return on Assets (ROA) | -49.98% | -29.79% | -645.82% | -5,663.30% | ||
| Return on Capital Employed (ROCE) | -52.40% | -30.10% | 279.00% | 106.50% | 62.50% | 32.50% |
| Earnings Yield | -235.83% | -45.27% | -205.88% | |||
| FCF Yield | -118.36% | -23.71% | -149.90% | |||
| Buyback Yield / Dilution | -435.44% | -237.34% | -336.69% | -193.25% |